Cargando…

Viscocanalostomy and combined phacoemulsification with viscocanalostomy: A five-year follow-up

PURPOSE: To assess the effectiveness and safety of viscocanalostomy (VC) and phaco-viscocanalostomy (PV) surgeries in eyes with a five-year follow-up. METHODS: Retrospective review of patients who underwent VC and PV between January 2010 and December 2012 in the Stanley Eye Unit Abergele, UK. Patien...

Descripción completa

Detalles Bibliográficos
Autores principales: Lyons, Conor M, Oehring, Daniela, Mathews, Divya
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Wolters Kluwer - Medknow 2022
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8917563/
https://www.ncbi.nlm.nih.gov/pubmed/34937228
http://dx.doi.org/10.4103/ijo.IJO_588_21
_version_ 1784668574684545024
author Lyons, Conor M
Oehring, Daniela
Mathews, Divya
author_facet Lyons, Conor M
Oehring, Daniela
Mathews, Divya
author_sort Lyons, Conor M
collection PubMed
description PURPOSE: To assess the effectiveness and safety of viscocanalostomy (VC) and phaco-viscocanalostomy (PV) surgeries in eyes with a five-year follow-up. METHODS: Retrospective review of patients who underwent VC and PV between January 2010 and December 2012 in the Stanley Eye Unit Abergele, UK. Patients were included for the analysis if they had a full 5-year follow-up or required redo surgery in the 5-year period. Success was defined as an intraocular pressure (IOP) of <21 mmHg. The subanalysis included IOP <16 mmHg, IOP reduction >20%, and IOP reduction >30%, the complication rate, and the drop in the use of glaucoma medications post-surgery. RESULTS: A total of 370 eyes from 303 patients were included for the analysis. The mean preoperative IOP was 23 mmHg ± 5.3 mmHg with an average of 3.0 ± 0.1 medications. By year 5, this was reduced to 14.3 mmHg ± 6.5 mmHg with a mean of 1.0+/- 0.9 medications; 47.8% of the eyes had an IOP of <21 mmHg by year 5 without medication with a total of 92.6% of the eyes reaching this target with medication. The main complication in this group was the perforation of the Trabeculo Descemet’s Window (TDW) but this was not associated with a poorer outcome. CONCLUSION: This large data set of eyes undergoing VC surgery demonstrates the effectiveness and safety of this technique over 5 years.
format Online
Article
Text
id pubmed-8917563
institution National Center for Biotechnology Information
language English
publishDate 2022
publisher Wolters Kluwer - Medknow
record_format MEDLINE/PubMed
spelling pubmed-89175632022-03-13 Viscocanalostomy and combined phacoemulsification with viscocanalostomy: A five-year follow-up Lyons, Conor M Oehring, Daniela Mathews, Divya Indian J Ophthalmol Special Focus, Glaucoma PURPOSE: To assess the effectiveness and safety of viscocanalostomy (VC) and phaco-viscocanalostomy (PV) surgeries in eyes with a five-year follow-up. METHODS: Retrospective review of patients who underwent VC and PV between January 2010 and December 2012 in the Stanley Eye Unit Abergele, UK. Patients were included for the analysis if they had a full 5-year follow-up or required redo surgery in the 5-year period. Success was defined as an intraocular pressure (IOP) of <21 mmHg. The subanalysis included IOP <16 mmHg, IOP reduction >20%, and IOP reduction >30%, the complication rate, and the drop in the use of glaucoma medications post-surgery. RESULTS: A total of 370 eyes from 303 patients were included for the analysis. The mean preoperative IOP was 23 mmHg ± 5.3 mmHg with an average of 3.0 ± 0.1 medications. By year 5, this was reduced to 14.3 mmHg ± 6.5 mmHg with a mean of 1.0+/- 0.9 medications; 47.8% of the eyes had an IOP of <21 mmHg by year 5 without medication with a total of 92.6% of the eyes reaching this target with medication. The main complication in this group was the perforation of the Trabeculo Descemet’s Window (TDW) but this was not associated with a poorer outcome. CONCLUSION: This large data set of eyes undergoing VC surgery demonstrates the effectiveness and safety of this technique over 5 years. Wolters Kluwer - Medknow 2022-01 2021-12-23 /pmc/articles/PMC8917563/ /pubmed/34937228 http://dx.doi.org/10.4103/ijo.IJO_588_21 Text en Copyright: © 2021 Indian Journal of Ophthalmology https://creativecommons.org/licenses/by-nc-sa/4.0/This is an open-access article distributed under the terms of the Creative Commons Attribution-Noncommercial-Share Alike 4.0 Unported, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.
spellingShingle Special Focus, Glaucoma
Lyons, Conor M
Oehring, Daniela
Mathews, Divya
Viscocanalostomy and combined phacoemulsification with viscocanalostomy: A five-year follow-up
title Viscocanalostomy and combined phacoemulsification with viscocanalostomy: A five-year follow-up
title_full Viscocanalostomy and combined phacoemulsification with viscocanalostomy: A five-year follow-up
title_fullStr Viscocanalostomy and combined phacoemulsification with viscocanalostomy: A five-year follow-up
title_full_unstemmed Viscocanalostomy and combined phacoemulsification with viscocanalostomy: A five-year follow-up
title_short Viscocanalostomy and combined phacoemulsification with viscocanalostomy: A five-year follow-up
title_sort viscocanalostomy and combined phacoemulsification with viscocanalostomy: a five-year follow-up
topic Special Focus, Glaucoma
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8917563/
https://www.ncbi.nlm.nih.gov/pubmed/34937228
http://dx.doi.org/10.4103/ijo.IJO_588_21
work_keys_str_mv AT lyonsconorm viscocanalostomyandcombinedphacoemulsificationwithviscocanalostomyafiveyearfollowup
AT oehringdaniela viscocanalostomyandcombinedphacoemulsificationwithviscocanalostomyafiveyearfollowup
AT mathewsdivya viscocanalostomyandcombinedphacoemulsificationwithviscocanalostomyafiveyearfollowup